Mechanism of nanostructured lipid carriers in promotion of absorption of poorly soluble drugs

LIU Jianqing; ZHANG Jing; ZHAO Jiali; SONG Hongtao

doi:10.3969/j.issn.1006-0111.2014.04.004

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective Nano-structured lipid carriers (NLC) is a concerned research area in pharmaceutics, which as a novel drug delivery system to promote oral absorption of poorly soluble drugs.The literatures were reviewed to explore and summarize the mechanism that nano-structured lipid carriers in promotion of the absorption of poorly soluble drugs.

Mechanism of nanostructured lipid carriers in promotion of absorption of poorly soluble drugs

1. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Pharmacy, Fujian Medical University, Fuzhou 350108, China

2. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China

3. Department of Pharmacy, Fuzhou General Hospital of Nanjing Military Region, Fuzhou 350025, China;School of Medicine, Xiamen University, Xiamen 361005, China

Received Date: 2013-05-28

Rev Recd Date: 2013-11-05

Key words:

Abstract: Objective Nano-structured lipid carriers (NLC) is a concerned research area in pharmaceutics, which as a novel drug delivery system to promote oral absorption of poorly soluble drugs.The literatures were reviewed to explore and summarize the mechanism that nano-structured lipid carriers in promotion of the absorption of poorly soluble drugs.

HTML

Reference (21)

[1]	高振东.新型纳米结构脂质载体给药系统的研究进展[J].中国药业,2013,22(4):93-94.
[2]	温许,胡雄伟,吴昊,等.纳米结构脂质载体用于难溶性药物口服传递研究进展[J].药学实践杂志,2012,30(4):254-257.
[3]	Mozafari MR. Nanoliposomes:preparation andanalysis[J].Methods Mol Biol,2010,605:29.
[4]	曹丰亮,郭晨煜,李其禄,等.纳米结构脂质载体的制备与应用研究进展[J].中国生化药物杂志,2012,33(1):93-96.
[5]	Cone RA.Barrier properties of mucus[J].Adv Drug Deliv Rev,2009,61:75-85.
[6]	Müller RH,Radtke M,Wissing SA.Nanostructured lipid matrices for improved microencapsuhtion of drugs[J].Int J Pharm,2002,242(1-2):121-128.
[7]	Sigfridssonk K, Lundquvist AJ, Strimfors M. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development[J].Drug Dev Ind Pharm,2009,35(12):1479-1486.
[8]	Muchow M, Maincent P, Müller RH. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement[J]. Drug Devel Industr Pharm, 2011, 37(1): 8-14.
[9]	Chakraborty S, Shukla D, Mishra B, et al. Lipid—an emerging platform for oral delivery of drugs with poor bioavailability[J]. Eur J Pharm Biopharm,2009,73:1-15.
[10]	Sahu MK, Soni GC, Prajapati SK. Formulation and characterization of topical nanostructured lipid carrier gel of flurbiprofen and its comparisonwith micellar gel prepation[J]. World J Pharm Pharm Sci,2012,1(3):1235-1247.
[11]	Luo YF,Chen DW,Ren LX,et al. Solid lipid nanopartcles for enhancing vinpocetines oral bioavailability[J]. Contr Rel, 2006, 114: 53- 59.
[12]	Thomson AB, Schoeller C, Keelan M, et al. Lipid absorption: passing through theunstirred layers, brush-border membrane, and beyond[J]. Can J Physiol Pharmacol, 1993, 71 (8):531-555.
[13]	孙明辉.西罗莫司自微乳化释药系统的研究[D].湖北:华中科技大学,2012.
[14]	Müller RH,Runge S,Ravelli V,et al.Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals[J].Int J Pharm,2006,317(1):82-89.
[15]	Elgart A, Cherniakov I, Aldouby Y, et al.Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS):the underlying mechanisms for amiodarone and talinolol[J].Pharm Res,2013(5):212-215.
[16]	Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability[J]. Int J Pharm,2010,394(1):179-185.
[17]	胥娜,钟文英,朱丹妮.固体脂质纳米粒在提高难溶性药物生物利用度中的应用[J].中华中医药学刊,2007,25(8):1605-1607.
[18]	Mu HL, Hφy CE. The digestion of dietary triacylglycerols[J]. Prog Lipid Res, 2004, 43(2):105-133.
[19]	Ravi D, Hywel DW, Dallas B, et al. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products[J]. Int J Pharm,2013,441(1):323-333.
[20]	Hans B, Jenneke P,Ruud J, et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model[J]. ACS Nano, 2011, 5 (5): 4091-4103.
[21]	Takeuchi H, Yamamoto H, Kawashima Y, et al. Mucoadhesive nanoparticulate systems for peptide drug delivery[J]. Adv Drug Deliv Rev,2001,47(1):39.

Message Board

Mechanism of nanostructured lipid carriers in promotion of absorption of poorly soluble drugs

doi: 10.3969/j.issn.1006-0111.2014.04.004

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views